Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma.

Pathology oncology research : POR - 1 Jan 2014

Krawczyk Paweł, Nicoś Marcin, Ramlau Rodryg, Powrózek Tomasz, Wojas-Krawczyk Kamila, Sura Sylwia, Jarosz Bożena, Szumiło Justyna, Warda Edward, Mazurkiewicz Tomasz, Sawicki Marek, Milanowski Janusz

Abstract excerpt

Poor prognosis of lung adenocarcinoma is associated with early occurrence of distant metastases. This type of non-small-cell lung carcinoma more frequently involves EGFR gene abnormalities, which determine the efficacy of EGFR tyrosine kinase inhibitor therapies (EGFR TKIs). It is probable that g...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ErbB Receptors
Share to Exons
Share to Incidence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Adenocarcinoma

Share to Adenocarcinoma of Lung

Share to Bone Neoplasms

Share to Smoking

Source

Open in PubMed Open full text

Identifiers

PMID: 23852459
DOI: 10.1007/s12253-013-9667-4
PMCID: PMC3889871

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23852459-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma.PMID 23852459Read ↗

EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?Semantic proximity Read ↗

[Impacts of EGFR 19 exon mutations on brain metastases in treatment-naïve patients with lung adenocarcinoma].Semantic proximity Read ↗

EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report.Semantic proximity Read ↗

Bone Metastases and the EGFR and KRAS Mutation Status in Lung Adenocarcinoma--The Results of Three Year Retrospective Analysis.Semantic proximity Read ↗

Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status.Semantic proximity Read ↗

The correlation between EGFR mutation status and the risk of brain metastasis in patients with lung adenocarcinoma.Semantic proximity Read ↗

Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.Semantic proximity Read ↗

Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lung.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.